573P Role of CA125 in patients included in the DESKTOP III/ENGOT-ov20 trial.
Saved in:
| Title: | 573P Role of CA125 in patients included in the DESKTOP III/ENGOT-ov20 trial. |
|---|---|
| Authors: | Lecuru, F.1 (AUTHOR), Sehouli, J.2 (AUTHOR), Vergote, I.B.3 (AUTHOR), Reuss, A.4 (AUTHOR), Classe, J-M.5 (AUTHOR), Hillemanns, P.6 (AUTHOR), Greggi, S.7 (AUTHOR), Mirza, M.R.8 (AUTHOR), Brachet, P.E.9 (AUTHOR), Follana, P.10 (AUTHOR), Raban, N.11 (AUTHOR), Hasenburg, A.12 (AUTHOR), Zang, R.13 (AUTHOR), Lindemann, K.14 (AUTHOR), Kim, J-W.15 (AUTHOR), Poveda, A.16 (AUTHOR), Raspagliesi, F.17 (AUTHOR), Haslund, C.A.18 (AUTHOR), du Bois, A.19 (AUTHOR), Harter, P.20 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS809-S809. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.701 |
